Iovance Biotherapeutics (IOVA) Q2 2024 Earnings

9MayConfirmed
Q2 2023
Q3 2023
Q4 2023
Q2 2024
-0.8
-0.67
-0.55
-0.42

Details

Expected EPS
-0.424345
Actual EPS
-0.42
Surprise EPS
0
Surprise Percent
+1.02%

Description

Iovance Biotherapeutics (IOVA) has reported earnings of -0.42 per share for Q2 2024.

0 Comments

Share your thoughts